logo-loader

Investor Update: SDX Energy hits stable production at South Disouq

Headlines from the Proactive UK newsroom.

SDX Energy (LON:SDX) has achieved stable production at its South Disouq concession in Egypt three months earlier than initially expected. Gas has been flowing since 7 November at a fixed price. 

Eco Atlantic (LON:ECO) and its partners on the Orinduik Block, offshore Guyana have agreed to enter the next exploration phase for the project. This first renewal period gives the partnership control of the licence to January 2023.

Futura Medical’s (LON:FUM) erectile disfunction treatment MED2005 missed its primary endpoint against a placebo in a phase III trial. The drug did score well against baseline, which provides a potentially quicker route to market.

 In an unscheduled trading update, Computacenter (LON:CCC) said profits and earnings in 2019 will be well ahead of previous expectations. The IT equipment supplier’s seen good growth in existing businesses allied to a recovery in the US.

Ted Baker’s (LON:TED) chief executive and executive chairman have stepped down following another grim trading update. Profits this year will be around £5mln, the dividend has been suspended and a drastic cost cutting review has been instigated.

Pub group JD Wetherspoon (LON:JDW) is to create 10,000 new jobs and open pubs in a host of small and medium-sized towns as part of a £200mln, four-year investment plan. Chairman Tim Martin said he’s looking forward to opening many more pubs.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of SDX Energy Inc named herein, including the promotion by the Company of SDX Energy Inc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

10 hours, 5 minutes ago

2 min read